Novo Nordisk A/S - share repurchase programme

{
  "signal_id": "e2a699af-8e2b-2518-e3c6-7fdc215b5b41",
  "signal_type": "news",
  "signal_subtype": "invests_into_assets",
  "detected_at": "2026-09-28T19:25:17+00:00",
  "company": {
    "name": "Novo Nordisk",
    "domain": "novonordisk.com"
  },
  "data": {
    "url": "https://www.globenewswire.com/news-release/2026/09/28/3369954/0/en/novo-nordisk-a-s-share-repurchase-programme.html",
    "title": "Novo Nordisk A/S - share repurchase programme",
    "assets": "B shares",
    "excerpt": "Bagsværd, Denmark, 28 September 2026 – On 6 May 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the \"Safe Harbour Rules\"). This programme is part of the overall share repurchase programme of up to DKK 15 billion to be executed during a 12-month period beginning 4 February 2026.",
    "summary": "Novo Nordisk reported further purchases of its own B shares as part of its ongoing buyback program.",
    "planning": false,
    "image_url": "https://mdb.ad-hoc-news.de/bild/bild-2671185_1920_1080.webp",
    "confidence": 0.9,
    "published_at": "2026-09-28T13:50:00Z",
    "effective_date": "2026-09-28",
    "article_sentence": "On 6 May 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the \"Safe Harbour Rules\")."
  }
}

curl https://signals.autobound.ai/v1/signals/e2a699af-8e2b-2518-e3c6-7fdc215b5b41 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"novonordisk.com","limit":20}'